#United States #Boston #Lindus Health #clinical operations #Heather Davis

Lindus Health Enhances Leadership with Heather Davis as VP of U.S Clinical Operations

In a significant move aimed at bolstering its operations, Lindus Health, often referred to as the "anti-CRO," has appointed Heather Davis as its new Vice President of U.S. Clinical Operations. This development reflects the company's commitment to streamline and enhance the efficiency of clinical trials across its expanding portfolio of studies in the United States.

A New Era for Lindus Health

Headquartered in Boston, Massachusetts, Lindus Health has made quite an impression in the life sciences field by conducting over 30 studies across various therapeutic areas and indications. Notable projects include a pivotal Phase III trial focusing on a novel treatment for major depressive disorder (MDD) and a 500-patient study supporting an FDA submission for an ovarian cancer treatment. The company collaborates with numerous innovative biotech, pharmaceutical, diagnostic, and medical device companies throughout North America, aiming to push the boundaries of what is achievable in clinical research.

To further enhance its U.S operations, Lindus Health has welcomed Heather Davis, a clinical research leader who brings over three decades of experience in clinical operations, project management, and executive leadership. Davis previously served as the Chief Operations Officer at Highline Sciences, a dedicated oncology-focused CRO. During her tenure, she played a key role in transforming the company from a seven-employee consultancy to a full-service CRO with more than 100 employees. Following the company's acquisition by Tempus, Heather continued as COO, where she focused on integrating advanced technology with clinical operations.

Heather's Vision for Innovation

Heather’s extensive background provides her with a unique perspective on the clinical trial landscape, having worked across biotechs and CROs, as well as in direct engagement with participants as a research coordinator. This holistic understanding allows her to grasp the dynamics between sponsors, CROs, clinical sites, and patients, setting the stage for more efficient trial delivery.

In her new role, Heather expresses excitement about the utilization of digital tools to streamline clinical operations more effectively. “Having seen firsthand how digital tools can streamline trial delivery within CROs, I’m excited to build on that experience at Lindus Health,” says Davis. She emphasizes the flexibility technology now provides in expediting clinical research processes and operating efficiently within a full-service CRO framework.

Heather has contributed to various studies in therapeutic areas such as pulmonary, immunology, respiratory, and notably oncology for the past decade. Her experience in oncology research, which involves strict regulatory requirements and high operational standards, showcases her dedication to quality and excellence, aligning perfectly with Lindus Health's goals.

Heather was particularly attracted to Lindus Health's integrated and patient-centric approach to clinical trials. “I was drawn to Lindus Health's one-stop-shop approach and its ability to deliver a fast, robust, tech-forward, and patient-centric all-in-one CRO solution,” she stated. With a company culture that empowers every team member to take ownership of their projects, she sees a bright future for clinical research innovation.

Future Directions

As Lindus Health seeks to expand its influence in the North American market, Heather’s leadership will be crucial. She will play a significant role in building and managing U.S. teams while overseeing the delivery of high-quality trials from initiation to completion, further strengthening the company’s operational backbone.

Emma Ogburn, Senior VP of Clinical Operations at Lindus Health, aptly remarked, “Heather's achievements in developing agile, high-performing teams, nuanced expertise in vertical tech integration, and focus on delivering streamlined trials seamlessly align with our company's mission and values.” The Lindus team is enthusiastic about having Heather at the helm of their U.S. clinical operations.

About Lindus Health

Established to revolutionize the clinical trial process, Lindus Health is pioneering faster and more reliable clinical trials for life science innovators. By implementing fixed-price, milestone-based contracts, and leveraging a unique software platform alongside world-class clinical operations teams, they are redefining trial execution.

With access to over 40 million Electronic Health Records and a growing list of partnerships with leading biotech, medical device, diagnostics, and consumer health companies, Lindus Health aims to remove the bottlenecks currently plaguing clinical trials. Their efforts have garnered industry recognition, including awards for outstanding patient recruitment and retention, marking them as a leader in the field.

To date, Lindus Health has executed trials across the U.S., UK, and Europe addressing various conditions including diabetes, asthma, hypertension, and more, raising over $80 million from notable investors. As they continue to innovate and expand, appointments like Heather Davis signify their commitment to operational excellence and groundbreaking advancements in clinical research.